Ekso Bionics raises ~$4.0M in registered direct offering of 2.97M shares at $1.55/share

EKSO BIONICS HOLDINGS, INC.

Sold 2,967,742 common shares at $1.55 each; net proceeds ~$4.0M after fees and expenses.
Offering closed on January 16, 2024; proceeds for general corporate purposes (R&D, SG&A, working capital).
Exercise price of May 2019 warrants (193,060 outstanding) reduced from $3.52 to $1.55 per share due to anti-dilution.
A.G.P./Alliance Global Partners acted as exclusive placement agent; fee of 7% of gross proceeds plus expense reimbursements.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.